Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT03037385What this trial is testingPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more Hoffmann-La Roche 590
Early research (Phase 1)Study completedNCT04641871What this trial is testingSym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor MalignanciesWho this might be right forMetastatic CancerSolid Tumor Symphogen A/S 78
Early research (Phase 1)Study completedNCT05585034What this trial is testingPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more Xencor, Inc. 60
Early research (Phase 1)Study completedNCT00537121What this trial is testingVorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerWho this might be right forEsophageal CancerGastric CancerLiver Cancer Roswell Park Cancer Institute 23
Testing effectiveness (Phase 2)Looking for participantsNCT04984733What this trial is testingTemozolomide + Nivolumab in MGMT Methylated Oesophagogastric CancerWho this might be right forAdenocarcinoma - GEJCancer of Esophagus University of Southampton 18
Early research (Phase 1)Looking for participantsNCT07348211What this trial is testingFirst in Human Study of SIM0610 in Solid TumorsWho this might be right forAdvanced Solid TumoursNon-Small Cell Lung CancerColorectal Cancer+2 more Jiangsu Simcere Pharmaceutical Co., Ltd. 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT04280081What this trial is testingSelpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET ActivationWho this might be right forSolid TumorMedullary Thyroid Cancer Eli Lilly and Company 77
Testing effectiveness (Phase 2)Study completedNCT00016900What this trial is testingPNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the EsophagusWho this might be right forEsophageal Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06953089What this trial is testingDB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsWho this might be right forSolid Tumors DualityBio Inc. 492
Testing effectiveness (Phase 2)Ended earlyNCT00493025What this trial is testingPaclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By SurgeryWho this might be right forEsophageal Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Testing effectiveness (Phase 2)UnknownNCT03047525What this trial is testingStudy of DC-CTL Combined With CIK for Advanced Solid TumorWho this might be right forColorectal CancerRenal Cell CarcinomaNasopharyngeal Carcinoma+1 more Xiaoyi Huang 200
Testing effectiveness (Phase 2)Study completedNCT01212822What this trial is testingBevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+17 more Fox Chase Cancer Center 20
Early research (Phase 1)Active Not RecruitingNCT06607185What this trial is testingThe Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more Eli Lilly and Company 750
Testing effectiveness (Phase 2)Study completedNCT02114658What this trial is testingSorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma PatientsWho this might be right forThyroid Carcinoma Bayer 18
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT04291300What this trial is testingLutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer PatientsWho this might be right forSalivary Gland CancerSalivary Duct CarcinomaAdenoid Cystic Carcinoma Radboud University Medical Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115